Analyses of serum concentrations of inflammatory cytokines, fatty acids, and oxidation products in the patients with age-related macular degeneration, diabetic retinopathy, and central serous chorioretinopathy

Analyses of serum concentrations of inflammatory cytokines, fatty acids, and oxidation products in the patients with age-related macular degeneration, diabetic retinopathy, and central serous chorioretinopathy - Analyses of serum concentrations of inflammatory cytokines, fatty acids, and oxidation products in the patients with age-related macular degeneration, diabetic retinopathy, and central serous chorioretinopathy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032946

Enrollment

400

Registered

2018-06-11

Start date

2018-06-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

age-related macular degeneration, diabetic retinopathy, central serous chorioretinopathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with age-related macular degeneration or diabetic retinopathy central serous chorioretinopathy control: Patients without age-related macular degeneration, diabetic retinopathy, and any other inflammatory diseases.

Exclusion criteria

Exclusion criteria: Patient intaking Omega-3 supplements or medications

Design outcomes

Primary

Measure	Time frame
serum levels of cytokine , fatty acid, and oxidation products and patients age, severity of the diseases	—

Countries

Japan

Contacts

Public ContactHiroki Kaneko

Nagoya University Hospital Ophthalmology

h-kaneko@med.nagoya-u.ac.jp052-744-2277

Outcome results